Arsenal Capital Partners Invests $449M in Certara

December 8, 2022

Arsenal Capital Partners closed a previously announced $449 million stock purchase in Certara, acquiring shares from funds controlled by EQT Private Equity and becoming a long-term minority investor. As part of the transaction Arsenal appointed Operating Partner David Spaight to Certara's board while Stephen McLean remains a director; Arsenal agreed to a two-year lock-up on the newly purchased shares.

Targets
Certara, Inc.
Sellers
Funds controlled by EQT Private Equity
Industry
Biotechnology
Location
New Jersey, United States
Transaction Type
Growth capital

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.